Molina Healthcare (MOH)
Runs Medicaid, Medicare and Marketplace health plans through state contracts and regulated insurance markets.
Something off on this page? Send us feedback.
Operates government-sponsored managed-care plans across Medicaid, Medicare and Marketplace programs in the United States. Revenue comes primarily from premiums tied to state contracts and regulated insurance markets, while growth combines procurement wins, local plan start-ups and acquisitions.
Operates Medicaid, Medicare and Marketplace health plans for members in the United States. The business arranges care through regulated managed-care plans, with an operating perimeter focused on government-funded or government-subsidized coverage.
Growth combines state procurement wins and renewals, local plan start-ups after awards, and acquisitions of plans or government-program contract assets. That model requires local operating readiness and continuing authorization to serve each market.
Execution centers on administering benefits and provider networks while managing premiums against medical utilization and member acuity. State contracts typically run for limited terms and may permit termination; care authorization remains subject to federal and state oversight. Premium-rate updates can also lag changes in medical costs.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 28, 2026 | Wells Fargo | Reiterate | Rating: —Target: $235 | Target: $220 |
| Jul 24, 2026 | RBC Capital | Reiterate | Rating: —Target: $248 | Target: $218 |
| Jul 24, 2026 | Barclays | Reiterate | Rating: —Target: $184 | Target: $180 |
| Jul 14, 2026 | Truist Financial | Target | Target: $205 | Target: $250 |
| Jul 14, 2026 | Jefferies | Target | Target: $160 | Target: $230 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $8.92B · Total debt $3.95B · Total assets $16.00B · Shareholders' equity $4.17B
- Revenue
- $10.87B
- Operating income
- $145.0M
- Net income
- $60.0M
No dividends on record.
| Institutions | 108.56% | 56.67M shares | |
|---|---|---|---|
| 634 holders · as of Jun 30, 2026 | |||
| Insiders | 29.37% | 15.33M shares | |
| 19 holders · as of Sep 3, 2026 | |||
| Strategic holders | 14.52% | 7.58M shares | |
| 2 holders · as of Feb 14, 2017 | |||
| Adds to | 152.45% | ||
52.20M company shares as of Sep 11, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 152.45%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Curtis PedersenInsider | 18.92% | 9.88M | filed Feb 14, 2017 |
BlackRock, Inc.Institution | 12.59% | 6.57M | as of Jun 30, 2026 |
Molina Marital TrustStrategic | 7.84% | 4.09M | filed Feb 14, 2017 |
SMALLCAP World Fund, Inc.Institution | 7.48% | 3.91M | filed Feb 14, 2019 |
AQR Capital Management LLCInstitution | 6.82% | 3.56M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 14, 2026 | Maurice Hebert | officer: Chief Accounting Officer | −600 | $191.55 |
| May 11, 2026 | Jeff D. Barlow | officer: Chief Legal Officer | −17,811 | $186.12 |
| Mar 12, 2026 | Ronna Romney | director | −506 | $146.92 |
| Feb 11, 2026 | Richard C. Zoretic | director | +800 | $125.16 |
| Nov 24, 2025 | Richard M. Schapiro | director | −357 | $143.02 |
- Centene
Largest overlap across Medicaid, Marketplace, and Medicare
- Elevance Health
Large-scale rival in Medicaid, Medicare, and ACA individual plans
- UnitedHealth Group
National Medicaid and Medicare rival with broad government reach
- CVS Health
Aetna-based competitor across Medicaid and Medicare programs
- Humana
Medicare-focused rival with expanding state-based Medicaid reach
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Molina Healthcare | $191.26 | −3.31% | $10.33B | 1,041.1 | 27.1 | 0.2 | −4.8% |
| Centene | $63.71 | −1.97% | $32.10B | — | 14.1 | 0.2 | +9.9% |
| Elevance Health | $403.45 | −1.43% | $88.77B | 18.2 | 14.8 | 0.4 | +0.8% |
| UnitedHealth Group | $373.53 | −1.07% | $342.88B | 24.3 | 17.5 | 0.8 | +0.4% |
| CVS Health | $87.49 | −0.13% | $111.77B | 23.2 | 10.8 | 0.3 | +7.3% |
| Humana | $372.92 | −1.50% | $45.39B | 35.9 | 30.2 | 0.3 | +26.2% |
| Median | 23.7 | 14.8 | 0.3 | +7.3% |